About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Ohio | 521 Studies

Clinical Trials Prostate CancerOhio

Prostate Cancer Clinical Trials in Ohio

Find 521 clinical trials for prostate cancer near Ohio. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Ohio

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 81-100 of 521 trials

Active not recruitingTwo Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT TrialThis phase III trial compares less intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in treating patients with high risk prostate cancer…NCT04513717·Fairbanks, Alaska and 601 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedProstate Cancer Prevention Study for Men With High Grade PIN (Prostatic Intraepithelial Neoplasia)The purpose of this study is to determine if toremifene citrate is effective and safe in the prevention of prostate cancer in men who have been diagnosed with high grade prostatic…NCT00106691·Huntsville, Alabama and 137 others

CompletedLenalidomide and GM-CSF in Treating Patients With Prostate CancerRATIONALE: Lenalidomide may stop the growth of prostate cancer by blocking blood flow to the tumor.NCT00939510·Cleveland, Ohio

CompletedTrial to Evaluate Safety and Immunogenicity of INO-5150 Alone or With INO-9012 in Men With Prostate CancerThis is a phase I, open-label trial to evaluate the safety and immunogenicity of INO 5150 alone or in combination with INO-9012 when delivered intramuscularly (IM) followed by…NCT02514213·Baltimore, Maryland and 9 others

CompletedChemotherapy, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Androgens can stimulate the growth of prostate cancer cells.NCT00016913·Washington D.C., District of Columbia and 22 others

RecruitingDESTINY-PANTUMOUR04This study will evaluate the effectiveness of T-DXd in patients with HER2-positive (IHC 3+) locally advanced, unresectable, or metastatic solid tumors who have received prior…NCT07124000·Birmingham, Alabama and 17 others

CompletedAssessment Of Dutasteride (AVODART) In Extending The Time To Progression Of Low-Risk, Localized Prostate Cancer In MenThe purpose of this study is to examine the effect of dutasteride on the inhibition of low-risk, localized prostate cancer progression in men who would otherwise receive no active…NCT00363311·Little Rock, Arkansas and 81 others

CompletedA Study to Learn How Well Darolutamide Administered Together With Androgen Deprivation Therapy (ADT) Works in Men With Metastatic Hormone-sensitive Prostate Cancer. Results Will be Compared With ADT Alone From a Previously Conducted Study.The purpose of the study is to assess if the addition of darolutamide to ADT compared with ADT alone would result in superior clinical efficacy in participants with metastatic…NCT05059236·Homewood, Alabama and 30 others

CompletedIntensive Diet and Exercise or Standard of Care in Improving Physical Function and Quality of Life in Patients With Prostate Cancer Undergoing Androgen Deprivation TherapyThis randomized pilot clinical trial studies intensive diet and exercise or standard of care in improving physical function and quality of life in patients with prostate cancer…NCT02050906·Columbus, Ohio

CompletedPilot Study Evaluating the Role of Histopathology Correlation in Treatment PlanningThis clinical research study tests the Uronav system. Patients with prostate cancer will be asked to take part in this study.NCT02681614·Cleveland, Ohio

Active not recruiting177Lu-PSMA-617 vs. Androgen Receptor-Directed Therapy in the Treatment of Progressive Metastatic Castrate Resistant Prostate CancerThe purpose of this study is to determine whether 177Lu-PSMA-617 improves the Radiographic progression-free survival (rPFS) or Overall Survival (OS) compared to a change in…NCT04689828·Denver, Colorado and 71 others

WithdrawnSingle-Port Versus Multi-Port Robotic Radical ProstatectomyThe purpose of this study is to compare two different techniques to perform the standard of care surgery to treat prostate cancer.NCT04696263·Cleveland, Ohio

TerminatedMRI Before Biopsy in Diagnosing Patients With Prostate CancerThis pilot clinical trial studies how well magnetic resonance imaging (MRI) before biopsy works in diagnosing patients with prostate cancer.NCT02131207·Cleveland, Ohio

RecruitingA Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)The purpose of this study is to evaluate the safety, efficacy, tolerability, and pharmacokinetics (PK) of FG-3246, a cluster of differentiation 46 (CD46) targeting antibody-drug…NCT06842498·Goodyear, Arizona and 22 others

CompletedTadalafil in Preventing Erectile Dysfunction in Patients With Prostate Cancer Treated With Radiation TherapyRATIONALE: Tadalafil may help prevent erectile dysfunction (ED) in patients with prostate cancer that has been treated with radiation therapy.NCT00931528·Birmingham, Alabama and 191 others

CompletedStudy of XB002 in Subjects With Solid Tumors (JEWEL-101)This is a Phase 1, open-label, multicenter, dose-escalation and expansion study evaluating the safety, tolerability, PK, pharmacodynamics, and clinical antitumor activity of XB002…NCT04925284·Birmingham, Alabama and 94 others

Active not recruitingA Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate CancerTo evaluate whether Fuzuloparib plus AA-P is superior to placebo plus AA-P as first-line treatment by assessment of radiographic progression-free survival (rPFS) in mCRPC subjects…NCT04691804·Anchorage, Alaska and 146 others

Active not recruitingRetrospective/Prospective Analysis of Surgical Outcomes of Robotic Prostatectomy at The JamesThis is a retrospective/prospective Analysis of surgical outcomes of robotic prostatectomy.NCT01643954·Columbus, Ohio

CompletedGM-CSF in Treating Patients With Relapsed Prostate CancerRATIONALE: Colony stimulating factors, such as GM CSF, may increase the number of immune cells found in bone marrow or peripheral blood.NCT00908141·Cleveland, Ohio

RecruitingAZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)The intention of the study is to demonstrate superiority of AZD2265 relative to standard of care treatments by assessment of radiographic progression-free survival (rPFS) and…NCT07611110·Dothan, Alabama and 131 others

PreviousPage 5 of 27Next

Other Conditions in Ohio

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma